This program is supported by an independent education grant from ITF Therapeutics. This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.
Join us for a live online course presented by leading expert Dr. Martina Sandonà and with insights from Muscular Dystrophy Association. Delve into the latest advancements in Duchenne Muscular Dystrophy (DMD) and gain insights into the mechanisms of action of emerging therapies, such as HDAC inhibitors, and their potential impact on DMD patient outcomes.
Accreditation: 1.5 AMA PRA Category 1 Credits™ is available for this education
Key Topics:
- Understanding HDAC Inhibitors: Explore the molecular mechanisms of HDAC inhibitors and their role in modulating gene expression.
- Clinical Trial Data: Evaluate the latest safety and efficacydata regarding the use of HDAC inhibitors in DMD, including outcomes on disease progression and muscle function.
- Optimizing Treatment Strategies: Discuss how to integrate latest therapies such as HDAC inhibitors into personalized treatment plans, considering factors such as disease stage, patient characteristics, and potential side effects.
- Long-Term Management: Explore strategies for long-term management of DMD patients, including the role of emerging therapies, supportive care, and monitoring.
Who is this for
This session is designed for healthcare professionals involved in the care of DMD patients, including:
- Pediatricians
- Neurologists
- Neuromuscular specialists
- Pediatric neurologists
- Geneticists
- Primary care physicians
Presented by
Martina Sandonà
Dr. Martina Sandonà is a postdoctoral researcher Università Cattolica del Sacro Cuore, Italy. Her research focuses on the role of post-translational modifications in muscular dystrophies, particularly the therapeutic potential of HDAC inhibitors. With a strong academic background, including a Master's degree in Chemistry and a PhD in Morphogenesis and Tissue Homeostasis, Dr. Sandona brings a wealth of knowledge and expertise to her work.
With address from the Muscular Dystrophy Association
Continuing Education Information
This continuing education activity will be provided by AffinityCE and MedAll. This activity will provide continuing education credit for physicians. A statement of participation is available to other attendees.
Faculty
Martina Sandona & Jessica Hubbard
Disclosures
Martina Sandonà has been the Principal Investigator for AFM-Telethon and an Inventor for Exofix Sr. She has no unapproved product related discussions to disclose.
Jessica Hubbard has no relevant financial relationships with ineligible companies to disclose and no unapproved product related discussions to disclose.
AffinityCE staff, MedAll staff, as well as planners and reviewers, have no relevant financial relationships with ineligible companies to disclose.
Mitigation of Relevant Financial Relationships
AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible companies. Relevant financial relationships were mitigated by the peer review of content by non-conflicted reviewers prior to the commencement of the program.
Activity Accreditation for Health Professions
Physicians
This activity will be planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and Medall. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this live activity a maximum of 1.5 AMA PRA Category 1 Credits™.
Physician Assistants
This activity will be planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this live activity a maximum of 1.5 AMA PRA Category 1 Credits™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners
This activity will be planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.
Nurses & Other Professionals
All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.
Participation Costs
There is no cost to participate in this program.